Comparing Efficacy and Safety of Oral Tranexamic Acid and 4% Topical Hydroquinone Cream in Melasma Treatment: A Randomized Controlled Clinical Trial and Review of Literature

1 Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutical approaches in melasma. Dermatol Clin. 2007;25(3):337–42.10.1016/j.det.2007.04.006Search in Google Scholar

2. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048–65.10.1016/j.jaad.2006.02.009Search in Google Scholar

3. Katsambas AD, Stratigos AJ, Lotti TM. Melasma. In: Katsambas AD, Lotti TM, editors. European handbook of dermatological treatments. 2nd ed. Berlin: Springer; 2003. p. 336.10.1007/978-3-662-07131-1_59Search in Google Scholar

4. Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689–97.10.1016/j.jaad.2010.12.046Search in Google Scholar

5. Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46(2):111–6.10.1016/j.jdermsci.2007.01.009Search in Google Scholar

6. Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol. 1997;15(1):35–43.10.1016/S0738-081X(96)00108-3Search in Google Scholar

7. Ejaz A, Raza N, Iftikhar N, Muzzafar F. Comparison of 30% salicylic acid with Jessner’s solution for superficial chemical peeling in epidermal melasma. J Coll Physicians Surg Pak. 2008;18(4):205–8.Search in Google Scholar

8. Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, et al. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg. 2006;32(5)-:626–31.10.1111/j.1524-4725.2006.32133.x16706756Search in Google Scholar

9. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57 (6):-1005–32.10.2165/00003495-199957060-0001710400410Search in Google Scholar

10. Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol. 1994;130(6):727–33.10.1001/archderm.1994.01690060057005Search in Google Scholar

11. Nijor T. Treatment of melasma with tranexamic acid. J Clin Res. 1979;13:3129–31.Search in Google Scholar

12. Leminen H, Hurskainen R. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012;4:413–21.Search in Google Scholar

13. Del Rosario E, Florez-Pollack S, Zapata L Jr, Hernandez K, Tovar-Garza A, Rodrigues M, et al. Randomized placebo controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol. 2017;78(2):363–9.10.1016/j.jaad.2017.09.05328987494Search in Google Scholar

14. Lajevardi V, Ghayoumi A, Abedini R, Hosseini H, Goodarzi A, Akbari Z, et al. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor and analyst-blinded, randomized controlled trial with a short-term follow-up. J Cosmet Dermatol. 2017;16(2):235–42.10.1111/jocd.1229127762489Search in Google Scholar

15. Cho HH, Choi M, Cho S, Lee JH. Role of tranexamic acid in melasma patients treated with IPL and low fluence QS Nd: YAG laser. J Dermatol Treat. 2013;24-(4):292–6.10.3109/09546634.2011.64322022103770Search in Google Scholar

16. Karn D, Kc S, Amatya A, Razouria EA, Timalsina M. Oral tranexamic acid for the treatment of melasma. Kathmandu Univ Med J (KUMJ). 2012;10(40):40–3.Search in Google Scholar

17. Kato H, Araki J, Eto H, Doi K, Hirai R, Kuno S, et al. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyper-pigmentation after Q-switched ruby laser. Dermatol Surg. 2011;37(5):605–10.10.1111/j.1524-4725.2011.01957.x21457392Search in Google Scholar

18. Sharma R, Mahajan VK, Mehta KS, Chauhan PS, Rawat R, Shiny TN. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol. 2017;42(7):721–34.10.1111/ced.1316428649780Search in Google Scholar

19. Wu S, Shi H, Wu H, Yan S, Guo J, Sun Y, et al. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg. 2012;36(4):964–70.10.1007/s00266-012-9899-922552446Search in Google Scholar

20. Lee HC, Thng TG, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75(2):385–92.10.1016/j.jaad.2016.03.00127206758Search in Google Scholar

21. Tan AWM, Sen P, Chua SH, Goh BK. Oral tranexamic acid lightens refractory melasma. Australas J Dermatol. 2017;58(3):e105–8.10.1111/ajd.1247427173008Search in Google Scholar

22. Shin JU, Park J, Oh SH, Lee JH. Oral tranexamic acid enhances the efficacy of low-fluence 1040-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized prospective trial. Dermatol Surg. 2013;39(3 Pt 1):435–42.10.1111/dsu.1206023278870Search in Google Scholar

23. Padhi T, Pradhan S. Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: an open labeled randomized comparative trial. Indian J Dermatol. 2015;60(5):520.10.4103/0019-5154.164416460144026538719Search in Google Scholar